πŸ‡ΊπŸ‡Έ FDA
Patent

US 8476229

Blood sugar-modulating polypeptides

granted A61KA61K38/04A61K38/16

Quick answer

US patent 8476229 (Blood sugar-modulating polypeptides) held by China Medical University expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/04, A61K38/16, A61P, A61P3/08